Search

Search Constraints

You searched for: Author/Creator Joly, Véronique

Search Results

2. Association between renin–angiotensin–aldosterone system blockers and outcome in coronavirus disease 2019: analysing in-hospital exposure generates a biased seemingly protective effect of treatment. Issue 2 (February 2021)

3. Brief Report: Efficacy and Safety of Efavirenz, Raltegravir, and Dolutegravir in HIV-1/TB Coinfection. A Multicenter Retrospective Cohort Study in France. (1st September 2022)

4. Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study. (February 2023)

6. Erratum to: Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients. (17th September 2021)

7. Erythematous maculopapular rash in monkeypox virus infection: A retrospective case series of 30 patients. (24th January 2023)

8. High virological suppression regardless of the genotypic susceptibility score after switching to a dolutegravir-based regimen: week 48 results in an observational cohort. (8th March 2018)

9. HIV-1 protease, Gag and gp41 baseline substitutions associated with virological response to a PI-based regimen. (14th February 2019)

10. Impact of Antiretroviral Drugs on Fracture Risk in HIV-Infected Individuals: A Case–Control Study Nested Within the French Hospital Database on HIV (FHDH-ANRS CO4). (1st February 2019)